VACCINE ANTIGENS AND USE THEREOF

COMPOSITIONS, METHODS, AND USES FOR POLYNUCLEOTIDE FORMULATIONS FOR DRYING AND PROLONGED STORAGE

HUMAN CTLA-4 PEPTIDE VACCINES AND USES THEREOF

SIGNAL SEQUENCES FOR NUCLEIC ACID VACCINES

NOVEL REOVIRUS-BASED VACCINE PLATFORM AND USE THEREOF

FREEZE-DRIED VIRAL COMBINATION VACCINE COMPOSITIONS AND PROCESS FOR PREPARATION THEREOF

Methods and Materials for Using Measles Viruses

ATTENUATED MUMPS VACCINE AND USES THEREOF

IMMUNE CHECKPOINT MULTIVALENT PARTICLES COMPOSITIONS AND METHODS OF USE

MEASLES VIRUS VACCINE EXPRESSING SARS-COV-2 PROTEIN(S)

MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE

METHOD AND COMPOSITION FOR ENHANCING THE IMMUNE RESPONSE

MEASLES-VECTORED COVID-19 IMMUNOGENIC COMPOSITIONS AND VACCINES

COMBINATION ANTIVIRAL THERAPY FOR MEASLES

F-GENOTYPE MUMPS VIRUS ATTENUATED STRAIN AND CONSTRUCTION METHOD THEREFOR AND APPLICATION THEREOF

Therapeutic Agent Effectiveness and its Route of Adminstration

Mumps virus as a potential oncolytic agent

Modified viruses

Methods and materials for using measles viruses

RECOMBINANT MUMPS VIRUS VACCINE EXPRESSING GENOTYPE G FUSION AND HEMAGGLUTININ-NEURAMINIDASE PROTEINS

RECOMBINANT RSV LIVE VACCINE STRAIN AND PRODUCTION METHOD THEREFOR

NON-PSYCHOACTIVE CANNABINOIDS AS ADJUVANTS TO ENHANCE MUCOSAL IMMUNITY

Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection

RECOMBINANT MEASLES VIRUSES EXPRESSING EPITOPES OF ANTIGENS OF RNA VIRUSES - USE FOR THE PREPARATION OF VACCINE COMPOSITIONS

System and method for microneedle delivery of microencapsulated vaccine and bioactive proteins

Recombinant measles viruses expressing epitopes of antigens of RNA viruses—use for the preparation of vaccine compositions

Recombinant measles vaccine expressing hTERT

Oral dissolving films containing microencapsulated vaccines and methods of making same

DOMINANT NEGATIVE LIGAND CHIMERIC ANTIGEN RECEPTOR SYSTEMS

Aseptic purification process for viruses

Methods and materials for detecting SNPs and administering measles virus

Lassa vaccine

Composition comprising an antigen and a substituted imidazo[1,2-a]pyrimidine for enhancing human immune response

Mumps virus as a potential oncolytic agent

Modified viruses

Recombinant measles viruses expressing epitopes of antigens of RNA viruses—use for the preparation of vaccine compositions

Use of a genetically modified infectious measles virus with enhanced pro-apoptotic properties (MV-deltaC virus) in cancer therapy

Recombinant mumps virus vaccine

Tobacco products

Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection

Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection

Recombinant Zika vaccines

Method and apparatus for microneedle transdermal delivery

Chromatography based purification strategies for viruses

Compositions and methods for stabilization of active agents

Manufacture of vaccines and compositions for the prevention of infections

Methods for the prevention of infections

Methods and materials for detecting SNPS and administering measles virus vaccinations

Oral dissolving films

Methods and compositions for therapeutic agents

Use of a genetically modified infectious measles virus with enhanced pro-apoptotic properties (MV-deltaC virus) in cancer therapy

Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus

Recombinant measles viruses expressing epitopes of antigens of RNA viruses—use for the preparation of vaccine compositions

Mumps virus as a potential oncolytic agent

Methods and products for treating and/or delaying onset of dysplastic lesions

Aseptic purification process for viruses

Method of Vaccination Comprising a Histone Deacetylase Inhibitor

Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection

Gene-modified measles virus for tumor treatment use

VIRUS VECTOR, CELL, AND CONSTRUCT

Antigen delivery system

COMPOSITIONS AND METHODS FOR STABILIZATION OF ACTIVE AGENTS

RECOMBINANT MUMPS VIRUS VACCINE

Adjuvant for mucosal vaccine

Microneedle-based transdermal delivery system and method of making same

Immunogenic composition for modulating the immune system and methods to treat bacterial infections in a subject

Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection

Nanospheres encapsulating bioactive material and method for formulation of nanospheres

Subunit vaccine platform based on multimeric ribonucleoproteins comprising nucleoproteins of a non-segmented negative-strand RNA virus as carriers of heterologous polypeptides

Nasal mucosal vaccine composition

Thermally stable vaccine formulations and microneedles

Bacterial vaccine and methods for manufacture thereof

Mucosal vaccine composition

Methods of immunization with varicella zoster virus antigen

ANTI-MEASLES CANCER IMMUNOTHERAPY

NON-SPECIFIC DELAYED-TYPE HYPERSENSITIVITY RESPONSE TO TREAT HERPES SIMPLEX VIRUS INFECTION

Recombinant measles viruses expressing epitopes of antigens of RNA viruses—use for the preparation of vaccine compositions

Single high dose of MVA induces a protective immune response in neonates and infants

Use of a genetically modified infectious measles virus with enhanced pro-apoptotic properties (MV-deltaC virus) in cancer therapy

COMPOSITIONS AND METHODS FOR GENERATING AN IMMUNE RESPONSE

Reverse genetics of negative-strand RNA viruses in yeast

Medicaments and methods for treating mesothelioma

Chimeric poly peptides and the therapeutic use thereof against a Flaviviridae infection

Combined measles-malaria vaccine

Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus

TRANSCUTANEOUS DELIVERY OF THERAPEUTIC AGENTS

COMPOSITIONS AND METHODS FOR STABILIZATION OF ACTIVE AGENTS

Viruses lacking epithelial cell receptor entry

Compositions and methods for activating innate and allergic immunity

ANTI-MEASLES CANCER IMMUNOTHERAPY

Method of vaccination comprising a histone deacetylase inhibitor

NON-SELF T-CELL EPITOPE FUSED TO AN ANTIBODY THAT RECOGNISES A TUMOUR-SPECIFIC CELL-SURFACE RECEPTOR AND USES THEREOF

Immunogenic composition for immune system modulation and use thereof, method for treating and preventing diseases, method for inducing cell regeneration and method for restoring immune response

Recombinant mumps virus vaccine

Vaccine injection, preparation method and use thereof

COMPOSITIONS INCLUDING TRANSFER FACTOR DERIVED FROM EGGS

Vaccines, methods of administering vaccines, methods and products for treating and/or delaying onset of dysplastic lesions, and wafers for oral administration

Recombinant measles viruses expressing epitopes of antigens of RNA viruses—use for the preparation of vaccine compositions

Recombinant Measles Virus Useful as a Bivalent Vaccine Against Measles and Malarial Infections

Compositions and methods for activating innate and allergic immunity

Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection

Combined measles-malaria vaccine

METHODS OF TREATING MEASLES INFECTIOUS DISEASE IN MAMMALS

CDNA corresponding to the antigenome of nonsegmented negative strand RNA viruses, and process for the production of such viruses encoding additional antigenically active proteins

Reverse genetics of negative-strand RNA viruses in yeast

Methods and Compositions for Stabilization of a Virus Vaccine

Stabilisation of Viral Microparticles

Transcutaneous delivery of therapeutic agents

Combined measles-human papilloma vaccine

Formulation for room temperature stabilization of a live attenuated bacterial vaccine

RECOMBINANT MODIFIED VACCINIA VIRUS MEASLES VACCINE

Viruses lacking epithelial cell receptor entry

ANTI-MEASLES CANCER IMMUNOTHERAPY

Medicaments and methods for treating mesothelioma

Chimeric poly peptides and the therapeutic use thereof against a Flaviviridae infection

RECOMBINANT MULTIVALENT VACCINE

NON-SPECIFIC DELAYED-TYPE HYPERSENSITIVITY RESPONSE TO TREAT HERPES SIMPLEX VIRUS INFECTION

COMPOSITIONS AND METHODS FOR ACTIVATING INNATE AND ALLERGIC IMMUNITY

Compositions and methods for activating innate and allergic immunity

MEASLES SUBUNIT VACCINE

METHODS OF TREATING MEASLES INFECTIOUS DISEASE IN MAMMALS

Immunotherapy of epithelial tumors using intralesional injection of antigens that induce a delayed type hypersensitivity reaction

cDNA corresponding to the antigenome of nonsegmented negative stranded RNA viruses and process for the production of such viruses

Infectious recombinant paramyxovirus from antigenomic cDNA

Rescue of mumps virus from CDNA

Rescue of mumps virus from cDNA

Stabilisation of viral microparticles

Recombinant measles viruses expressing epitopes of antigens of RNA viruses - use for the preparation of vaccine compositions

Recombinant therapeutic fusion proteins

Immunotherapy of epithelial tumors using intralesional injection of antigens that induce a delayed type hypersensitivity reaction

Neisserial vaccine compositions and methods

Measles subunit vaccine

Microencapsulated DNA for vaccination and gene therapy

Transient expression of biologic materials